-
Mashup Score: 7
This secondary analysis of a randomized clinical trial evaluates the association between treatment with dapagliflozin vs placebo and improvement in components of the Kansas City Cardiomyopathy Questionnaire.
Source: jamanetwork.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11ESC Heart Failure (HF) 2023 Highlights - 11 month(s) ago
European Society of Cardiology (ESC) Heart Failure (HF) 2023 congress took place in Prague (20-23 May 2023). Hereby the top highlights.
Source: Cardiology UpdateCategories: Cardiologists, Latest HeadlinesTweet-
RT @CardiolUpdate: ESC #Heartfailure2023 Congress highlights👉https://t.co/sh11aeyLwx @hvanspall @ShelleyZieroth @gcfmd @chadialraies @mirv…
-
-
Mashup Score: 0Late breaking clinical trials: chronic HF and cardiomyopathies from Heart Failure 2023 on ESC 365 - 11 month(s) ago
Access this Late-Breaking Science on Treatment chaired by Professor F. Ruschitzka (Switzerland,CH),Professor P. Seferovic (Serbia,RS),Associate Professor C. Tocchetti (Italy,IT).
Source: esc365.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Late-Breaking clinical trials: chronic HF and cardiomyopathies. #HeartFailure2023 in Prague had an exceptionally high number of Late-Breaking Clinical Trials with high-quality, practice-changing evidence. Watch this free session on #ESC365 https://t.co/0DBVxoUe7D #HFA_ESC https://t.co/hDJqksFQbs
-
-
Mashup Score: 2ESC Heart Failure (HF) 2023 Highlights - 11 month(s) ago
European Society of Cardiology (ESC) Heart Failure (HF) 2023 congress took place in Prague (20-23 May 2023). Hereby the top highlights.
Source: Cardiology UpdateCategories: Cardiologists, Latest HeadlinesTweet-
RT @CardiolUpdate: ESC #Heartfailure2023 Congress highlights👉https://t.co/sh11aeyLwx @hvanspall @ShelleyZieroth @gcfmd @chadialraies @mirv…
-
-
Mashup Score: 1ESC Heart Failure (HF) 2023 Highlights - 11 month(s) ago
European Society of Cardiology (ESC) Heart Failure (HF) 2023 congress took place in Prague (20-23 May 2023). Hereby the top highlights.
Source: Cardiology UpdateCategories: Cardiology News and Journals, Latest HeadlinesTweet-
ESC #Heartfailure2023 Congress highlights👉https://t.co/sh11aeyLwx @hvanspall @ShelleyZieroth @gcfmd @chadialraies @mirvatalasnag @mmamas1973 @manesh_patelMD @djc795 @Almanfi_Cardio @DrAmirKaki @DocSavageTJU @ZaherFanari @rajivxgulati @KaulP @torresviera @HFA_President @escardio https://t.co/XaOIaAfxhr
-
-
Mashup Score: 0Conference News | tctmd.com - 11 month(s) ago
Hub page
Source: TCTMD.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Stay up to date with the latest news from major cardiovascular conferences. This week, TCTMD is covering ESC #HeartFailure2023, #EAS2023, #SCAI2023, and #ESOC2023! Our journalists are all over the world, reporting on TRACER-HF, ARCADIA, BIOMAG-1, and more: https://t.co/gucTMMS2hP
-
-
Mashup Score: 3TRACER-HF: Effects of Trientine-HCL in Patients With HFrEF - American College of Cardiology - 11 month(s) ago
The addition of trientine-HCL to usual care was well-tolerated in patients with heart failure with reduced ejection fraction (HFrEF), based on findings from the TRACER-HF trial presented May 20 during ESC’s Heart Failure 2023 meeting in Prague. Of note, the 300 mg dose of the oral copper chelator considerably reduced NT-proBNP at four and eight weeks, according to James L. Januzzi Jr., MD, FACC,…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. @JJheart_doc presented findings from the TRACER-HF trial at #HeartFailure2023. Results of the trial showed the addition of trientine-HCL to usual care was well-tolerated in patients with #HFrEF. Read more: https://t.co/511Bqd3Ai8 #HeartFailure
-
-
Mashup Score: 7HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi - 11 month(s) ago
ESC-HFA 2023 – Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) joined by Dr James Januzzi (Massachusetts General Hospital, US) to discuss late-breaking science highlights
Source: www.cfrjournal.comCategories: Cardiologists, Latest HeadlinesTweet-
Mesmerizing, beautiful, memorable #Prague! If you didn’t make it to the city or online for #HeartFailure2023, you can hear a recap of #LBCTs via @radcliffeCARDIO here: 🎞️ https://t.co/sejNRRatjB https://t.co/6PEH17SoHW
-
-
Mashup Score: 0The Diagnosis of Heart Failure is More Often Missed than Made Especially for Women - 11 month(s) ago
May 23, 2023 — The diagnosis of  heart failure is usually missed, denying patients treatments that could improve wellbeing and reduce mortality. That’s the finding from a late breaking science presentation today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC).1 “For patients with heart failure, lifestyle advice, medicines and devices can improve symptoms,…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @escardio #GreaterGlasgow and #ClydePopulationAnalysis presented in a #latebreaking #science session at Heart Failure 2023: https://t.co/4texrlCkBA #HeartFailure2023
-
-
Mashup Score: 0Sacubitril/Valsartan Shows Benefit in Heart Failure with Ejection Fraction Above 40% - 11 month(s) ago
May 23, 2023 — Sacubitril/valsartan leads to greater reduction in plasma NT-proBNP levels compared to valsartan alone after stabilization for worsening heart failure in patients with an ejection fraction (EF) above 40%, according to late breaking science presented today at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC),1 and published in the Journal of the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @escardio @dukemedicine @robmentz #PARAGLIDE_HF trial presented in a #latebreaking science session at Heart Failure 2023: https://t.co/Kc05kppFTa #HeartFailure2023
-
This analysis examined the effect of #dapagliflozin on the 23 individual components of the #KCCQ in #DELIVER. https://t.co/hbdrJ62UrQ @PeikertA @AlvinChandraMD @mvaduganathan @scottdsolomon #HeartFailure2023